<unk>  should not be prescribed for people who are at increased risks for osteosarcoma. This includes those with Paget's Disease of bone or unexplained elevations of serum alkaline phosphate, open epiphysis, or prior radiation therapy involving the skeleton. In the animal studies and in one human case report, it was found to potentially be associated with developing osteosarcoma in test subjects after over 2 years of use. Patients should not start<unk>  until any vitamin D deficiency is corrected.
Teriparatide
Denosumab
Bolazine capronate
Zoledronic acid
Medronic acid
Alendronic acid
Risedronic acid
Ibandronic acid